Sequential CD34+ and CD4+ cell selection from leukapheresis components.

I J Webb, M Beach, J F Daley, D M Schott, K C Anderson
{"title":"Sequential CD34+ and CD4+ cell selection from leukapheresis components.","authors":"I J Webb,&nbsp;M Beach,&nbsp;J F Daley,&nbsp;D M Schott,&nbsp;K C Anderson","doi":"10.1089/scd.1.1998.7.169","DOIUrl":null,"url":null,"abstract":"<p><p>We tested the feasibility of sequential selection of CD34+ and CD4+ cell-enriched fractions from aliquots of five autologous leukapheresis components. CD34+ cells were selected from a median 8.0 x 10(8) mononuclear cells using the CellPro CEPRATE LC cell separation system. All cells in the CD34-depleted fraction (median 4.8 x 10(8), range 0.6-10.0 x 10(8) were then incubated with the appropriate antibodies for CD4+ cell selection and passed through a second LC column. Median target cell purities of the CD34+ cell-enriched fraction and CD4+ cell-enriched fraction were 90.5% and 86.0%, respectively. This study demonstrates that high purity CD34+ and CD4+ cell-enriched fractions can be isolated sequentially from leukapheresis components. In addition, CD8+ lymphocytes, implicated in graft-versus-host disease, were depleted in the course of both positive selection procedures. This approach could decrease the number of donor procedures by providing separate CD34(+)-enriched and CD4(+)-enriched populations for allogeneic peripheral blood progenitor cell transplantation and subsequent donor lymphocyte infusion from the same leukapheresis component.</p>","PeriodicalId":77208,"journal":{"name":"Journal of hematotherapy","volume":"7 2","pages":"169-74"},"PeriodicalIF":0.0000,"publicationDate":"1998-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/scd.1.1998.7.169","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of hematotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/scd.1.1998.7.169","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

We tested the feasibility of sequential selection of CD34+ and CD4+ cell-enriched fractions from aliquots of five autologous leukapheresis components. CD34+ cells were selected from a median 8.0 x 10(8) mononuclear cells using the CellPro CEPRATE LC cell separation system. All cells in the CD34-depleted fraction (median 4.8 x 10(8), range 0.6-10.0 x 10(8) were then incubated with the appropriate antibodies for CD4+ cell selection and passed through a second LC column. Median target cell purities of the CD34+ cell-enriched fraction and CD4+ cell-enriched fraction were 90.5% and 86.0%, respectively. This study demonstrates that high purity CD34+ and CD4+ cell-enriched fractions can be isolated sequentially from leukapheresis components. In addition, CD8+ lymphocytes, implicated in graft-versus-host disease, were depleted in the course of both positive selection procedures. This approach could decrease the number of donor procedures by providing separate CD34(+)-enriched and CD4(+)-enriched populations for allogeneic peripheral blood progenitor cell transplantation and subsequent donor lymphocyte infusion from the same leukapheresis component.

序列CD34+和CD4+细胞选择从白细胞分离组分。
我们测试了从五种自体白细胞分离成分的等分液中顺序选择CD34+和CD4+细胞富集组分的可行性。使用CellPro CEPRATE LC细胞分离系统从中位数为8.0 x 10(8)个单核细胞中选择CD34+细胞。cd34缺失部分(中位数4.8 x 10(8),范围0.6-10.0 x 10(8))中的所有细胞与CD4+细胞选择的适当抗体一起孵育,并通过第二个LC柱。CD34+细胞富集部分和CD4+细胞富集部分的中位靶细胞纯度分别为90.5%和86.0%。本研究表明,高纯度的CD34+和CD4+细胞富集组分可以依次从白细胞分离组分中分离出来。此外,与移植物抗宿主病有关的CD8+淋巴细胞在两种阳性选择过程中都被耗尽。这种方法可以通过提供不同的CD34(+)富集和CD4(+)富集人群用于同种异体外周血祖细胞移植和随后来自相同白细胞分离成分的供体淋巴细胞输注,从而减少供体手术的数量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书